2011
DOI: 10.1007/s11882-011-0207-6
|View full text |Cite
|
Sign up to set email alerts
|

The Emerging Role of Interleukin-1β in Autoinflammatory Diseases

Abstract: The autoinflammatory syndromes are a group of multisystem disorders characterized by recurrent episodes of fever and systemic inflammation affecting the eyes, joints, skin, and serosal surfaces in the absence of an immune reaction. Recent advances have revealed the importance of interleukin-1β, not only in the pathogenesis of many of these rare inherited diseases, but also in acquired diseases. The development and availability of anti-interleukin-1β therapeutics have introduced the possibility of proof-of-conc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
22
0

Year Published

2012
2012
2020
2020

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 32 publications
(24 citation statements)
references
References 75 publications
2
22
0
Order By: Relevance
“…It is known that monosodium urate crystals engulfed by phagocytes cause an intracellular electrolyte disturbance that provokes inflammasome activation with subsequent release of cytokines, notably interleukin-1β (IL-1β) 7. The clinical presentation of our case is similar to that observed in autoinflammatory syndromes mediated by IL-1β which are characterised by recurrent episodes of fever, disorientation and leucocytosis affecting the joints, skin and serosal surfaces 8. Moreover, the release of cytokines stimulates endothelial cells, leading to vasodilatation, increased permeability to plasma proteins and the recruitment of leukocytes into tissues 9…”
Section: Discussionsupporting
confidence: 61%
“…It is known that monosodium urate crystals engulfed by phagocytes cause an intracellular electrolyte disturbance that provokes inflammasome activation with subsequent release of cytokines, notably interleukin-1β (IL-1β) 7. The clinical presentation of our case is similar to that observed in autoinflammatory syndromes mediated by IL-1β which are characterised by recurrent episodes of fever, disorientation and leucocytosis affecting the joints, skin and serosal surfaces 8. Moreover, the release of cytokines stimulates endothelial cells, leading to vasodilatation, increased permeability to plasma proteins and the recruitment of leukocytes into tissues 9…”
Section: Discussionsupporting
confidence: 61%
“…Having established that LPS induced widespread changes in the expression of lncRNAs and eRNAs in human monocytes that were located close to differentially expressed inflammatory genes, it was important to determine whether these were of functional relevance. Of particular interest for regulation of the innate immune response, was our identification of multiple non-coding transcripts that are situated close to the IL1β gene, an important cytokine that stimulates inflammatory responses in multiple cell types and whose overproduction has been implicated in autoimmune diseases2841. These included a downstream eRNA ( eRNA-IL1β-eRNA ) and an upstream mRNA-flanking RBT ( IL1β-RBT46 ).…”
Section: Discussionmentioning
confidence: 99%
“…The overproduction of proinflammatory mediators and cytokines by activated macrophages causes various inflammatory diseases (Tsatsanis et al 2006;Keystone and Ware 2010;Lane and Lachmann 2011;Kalinski 2012;Rossi et al 2015). Therefore, identifying new agents capable of lowering proinflammatory reactions are essential for the alleviation of a number of inflammation-related disorders attributed to macrophage activation.…”
Section: Discussionmentioning
confidence: 99%
“…The activated macrophages secrete proinflammatory mediators, such as nitric oxide (NO) and prostaglandin E 2 (PGE 2 ), which are synthesized by inducible NO synthase (iNOS) and cyclooxygenase-2 (COX-2), respectively (Tsatsanis et al 2006;Kalinski 2012). They also produce inflammatory cytokines, such as tumor necrosis factor-α (TNF-α), interleukin (IL)-6, and IL-1β (Keystone and Ware 2010;Lane and Lachmann 2011;Lee et al 2015;Rossi et al 2015). Therefore, the inhibition of macrophage activation has been suggested as a potential therapeutic goal in relieving the progression of inflammatory diseases.…”
Section: Introductionmentioning
confidence: 99%